
Rapid Identification of Pathogenic Bacteria and Sepsis DiagnosisAward last edited on: 5/2/2022
Sponsored Program
SBIRAwarding Agency
NIH : NIAIDTotal Award Amount
$5,879,445Award Phase
2Solicitation Topic Code
855Principal Investigator
Ray A MartinoCompany Information
Isense Medical Corporation (AKA: iSense LLC~Metabolomx)
500 South Australian Avenue Suite 120
West Palm Beach, FL 33401
West Palm Beach, FL 33401
(561) 655-5588 |
admin@metabolomx.com |
www.metabolomx.com |
Location: Single
Congr. District: 21
County: Palm Beach
Congr. District: 21
County: Palm Beach
Phase I
Contract Number: 1R43AI094781-01A1Start Date: 3/15/2012 Completed: 2/28/2013
Phase I year
2012Phase I Amount
$300,000Public Health Relevance:
The proposed research effort will develop and test a novel high-dimensional colorimetric sensor array technology for the detection and identification of bacteria responsible for sepsis. The proposed effort, if successful, will yield a rapid diagnostic tool for sepsis, allowing prompt delivery of appropriate antibiotic treatment and reduced health care costs.
Phase II
Contract Number: 2R44AI094781-02Start Date: 3/15/2012 Completed: 2/28/2015
Phase II year
2013(last award dollars: 2018)
Phase II Amount
$5,579,445Public Health Relevance:
The proposed research effort will develop and test a novel high-dimensional colorimetric sensor array technology for the detection and identification of bacteria responsible for sepsis. The proposed effort, if successful, will yield a rapid diagnostic tool for sepsis, allowing prompt delivery of appropriate antibiotic treatment and reduced health care costs.
Public Health Relevance Statement:
The proposed research effort will develop and test a novel high-dimensional colorimetric sensor array technology for the detection and identification of bacteria responsible for sepsis. The proposed effort, if successful, will yield a rapid diagnostic tool for sepsis, allowing prompt delivery of appropriate antibiotic treatment and reduced health care costs.
Project Terms:
Affect; Antibiotic Therapy; Antibiotics; Bacteria; base; biomarker; Blood; Breath Tests; Cause of Death; Clinical; clinically relevant; Collaborations; cost; Critical Illness; design; Detection; Development; Diagnosis; Diagnostic; Diagnostic Procedure; Disease; Drug resistance; Elderly; Feasibility Studies; Future; Goals; Growth; Health; Health Care Costs; health care quality; Hour; Immune; improved; Intensive Care Units; Liquid substance; Malignant neoplasm of lung; Medical; medical schools; Metabolic; microorganism culture; Monitor; Mortality Vital Statistics; novel; Optical Readers; pathogen; pathogenic bacteria; Patients; Phase; Pigments; point of care; prototype; Reader; Research; research study; response; sensor; Sepsis; Sinusitis; software development; Solid; System; Technology; Testing; Time; tool; Work